Shed is a high-performance topical solution engineered specifically for the female biological profile to combat thinning and promote hair density. Utilizing a clinically-backed 2% Minoxidil base, this formula works by revitalizing dormant follicles and extending the Anagen (growth) phase of the hair cycle. Unlike generic options, Shed is designed for ease of integration into a daily beauty routine, providing a professional-grade intervention for women experiencing early-stage androgenetic alopecia or stress-induced thinning.
Hair thinning in women is often driven by a shortening of the growth phase and the miniaturization of hair follicles. Shed addresses these biological hurdles by increasing blood flow directly to the scalp, ensuring that follicles receive the oxygen and nutrients required for robust hair production.
Shutterstock
Core Active Mechanism: 2% Minoxidil
The primary active ingredient is Minoxidil 2%, the only FDA-approved topical ingredient clinically proven to regrow hair in women.
Vasodilation: It acts as a peripheral vasodilator, widening blood vessels to improve the microcirculation surrounding the hair bulb.
Follicular Awakening: By shifting follicles from the Telogen (resting) phase back into the Anagen (growth) phase, Shed helps restore visible density over time.
Diameter Enhancement: Regular application has been shown to increase the actual diameter of the hair shaft, resulting in a fuller, more voluminous appearance.
Key Performance Benefits
Clinically-Proven Regrowth: Targets the root cause of thinning to produce measurable increases in hair count within 3–6 months of consistent use.
Hormonal Neutrality: Designed to work with the female endocrine system, providing a safe alternative to more aggressive systemic hair loss treatments.
Residue-Free Formulation: Unlike standard foam or oil-heavy products, Shed is formulated for quick absorption, allowing for styling immediately after application.
Usage Protocol & Clinical Expectations
Application: Apply 1ml of the solution directly onto the scalp in the hair loss area twice daily.
Consistency: Results are cumulative. Discontinuing use may lead to a reversal of the regrowth as the follicles return to their previous cycle.
Safety Profile: Formulated for topical use only. Users may experience a temporary "shedding" phase in the first 2-4 weeks—a clinical sign that the product is successfully pushing out old hairs to make room for new, stronger growth.
%201.avif)
